chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Haemoptysis, Nasopharyngitis, Vaccination complication, Vasculitis
Clinical narrative: vasculitis; coughing up blood; really bad head cold; dizzy; Started gettting sick; A spontaneous report received from a Consumer concerning, 79-year-old, female patient who received dose of Moderna COVID-19 vaccine experienced Vasculitis.   The patient's medical history included Afib. Patient's concomitant included Eliquis.    On 04FEB2021, the patient received their 1st dose of the two planned doses of mRNA-1273 in left arm (Batch #: unknown) intramuscularly for prophylaxis of COVID-19 infection.   Patient daughter reports her mother who is 79-year-old female with no underlining health issues other than Afib, which she takes blood thinners for has been in ICU since 10FEB2021. Patient daughter stated that she was told her mother has vasculitis as a result of the Moderna Covid-19 vaccine.   Patient daughter stated that her mother started getting sick on 06Feb2021. She stated her mother started coughing up blood on Sunday 07FEB2021. She stated her mother also had a bad head cold and was dizzy. Patient daughter stated that her mother has some genetic predisposition and the Moderna COVID-19 vaccine triggered it.   Patient daughter stated that her mother doctor advised her not to receive the 2nd dose of the Moderna COVID-19 vaccine.   Patient treatment included Chemotherapy Infusion (Rituxan) and Blood Transfusion.   Action taken with mRNA-1273 in response to the event was withdrawn.   The outcome of the event was unknown/not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Fatigue, Headache, Myalgia, Pyrexia
Clinical narrative: fever; fainting spell; fatigue; cough; headache; myalgias; Case reference number MOD-2021-013971 is a spontaneous case report sent by a Physician on 25-JAN-2021 00:00:00 , which refers to a Female aged 52 Years .  On 24-Dec-2020  the patient took Moderna COVID-19 vaccination. Some  2 days later,  the patient developed fainting.  The next day of vaccination the patient also developed cough,headache,myalgia,fever,fatigue. The patient experienced the following serious criteria: Medically Significant. The eventual diagnosis made on was Syncope .  The Physician did not declare any relatedness between fainting and Moderna COVID-19 Vaccine.  The medical reviewer may provide a case evaluation statement, including other possible etiological and confounding factors, e.g. (only limited information has been obtained so far, it is difficult to assess the cause and effect relationship; the co-medications y and x should also be considered causative as the reported event is labeled for both drugs; the company's view is the event is not due to the drug for the following reasons  (probably due to pre existing disease); there is no plausible mechanism to implicate the drug.  .   Terse Narrative (for narratives and signal review) Brief 3 line summary of above for Regulatory Authority listing: Report Source- Physician,  Age- 52 Years,  Sex- Female,  Suspect Drug- Moderna COVID-19 Vaccine,  Treatment-    Diagnosis\Outcome- fatigue - Recovered/Resolved,fainting - Recovered/Resolved,fever - Recovered/Resolved,myalgias - Recovered/Resolved,headache - Recovered/Resolved,cough - Recovered/Resolved.; Reporter's Comments: Patient ID:     Investigator Site:   Case reference number MOD-2021-013971 is a clinical trial case report which refers to a 52 Years old Female patient.  The patient experienced fainting which resulted in medically significant .    .  The patients started Moderna COVID-19 Vaccine on  .  Some  2 days  later, the patient developed fainting.'  Relevant laboratory results included   and relevant physical signs were <LIST PHYSICAL SYMPTOMS>. The patient experienced the following serious criteria: -Medically Significant  The eventual diagnosis made was Syncope .The event(s) were:  fatigue - Recovered/Resolved,fainting - Recovered/Resolved,fever - Recovered/Resolved,myalgias - Recovered/Resolved,headache - Recovered/Resolved,cough - Recovered/Resolved.  Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Syncope
Clinical narrative: fever; fainting spell; fatigue; cough; headache; myalgias; Case reference number MOD-2021-013971 is a spontaneous case report sent by a Physician on 25-JAN-2021 00:00:00 , which refers to a Female aged 52 Years .  On 24-Dec-2020  the patient took Moderna COVID-19 vaccination. Some  2 days later,  the patient developed fainting.  The next day of vaccination the patient also developed cough,headache,myalgia,fever,fatigue. The patient experienced the following serious criteria: Medically Significant. The eventual diagnosis made on was Syncope .  The Physician did not declare any relatedness between fainting and Moderna COVID-19 Vaccine.  The medical reviewer may provide a case evaluation statement, including other possible etiological and confounding factors, e.g. (only limited information has been obtained so far, it is difficult to assess the cause and effect relationship; the co-medications y and x should also be considered causative as the reported event is labeled for both drugs; the company's view is the event is not due to the drug for the following reasons  (probably due to pre existing disease); there is no plausible mechanism to implicate the drug.  .   Terse Narrative (for narratives and signal review) Brief 3 line summary of above for Regulatory Authority listing: Report Source- Physician,  Age- 52 Years,  Sex- Female,  Suspect Drug- Moderna COVID-19 Vaccine,  Treatment-    Diagnosis\Outcome- fatigue - Recovered/Resolved,fainting - Recovered/Resolved,fever - Recovered/Resolved,myalgias - Recovered/Resolved,headache - Recovered/Resolved,cough - Recovered/Resolved.; Reporter's Comments: Patient ID:     Investigator Site:   Case reference number MOD-2021-013971 is a clinical trial case report which refers to a 52 Years old Female patient.  The patient experienced fainting which resulted in medically significant .    .  The patients started Moderna COVID-19 Vaccine on  .  Some  2 days  later, the patient developed fainting.'  Relevant laboratory results included   and relevant physical signs were <LIST PHYSICAL SYMPTOMS>. The patient experienced the following serious criteria: -Medically Significant  The eventual diagnosis made was Syncope .The event(s) were:  fatigue - Recovered/Resolved,fainting - Recovered/Resolved,fever - Recovered/Resolved,myalgias - Recovered/Resolved,headache - Recovered/Resolved,cough - Recovered/Resolved.  Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Dysarthria, Pain in extremity, Swollen tongue
Clinical narrative: Slurry speech; Swollen tongue; Sore arm; A spontaneous report was received from a consumer concerning a male patient of 72 year old, who was received Moderna's COVID-19 vaccine(Mrna-1273) and experienced sore arm,slurry speech and swollen tongue.  The patients medical history,as provided by the reporter, included chemotherapy.No Concomitant medications were reported.  On 12 feb 2021,prior to the onset of events, the Patient received their second of two planned dose of Mrna-1273(Lot number:026L20A) vaccine intramuscularly for prophylaxis of COVID-19 infection.  On 12 feb 2021,after taking vaccine patient experienced soreness in arm.On the second day he woke up with slurry speech and swollen tongue. Patient was Admitted emergency room where he was kept overnight for observation and treatment.  Treatment for the event included hospitalization.  The outcome for the event sore arm,blurred speech and swollen tongue was not mentioned.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.  Further information has been requested.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram head, Laboratory test, Seizure
Clinical narrative: Two complex seizures; An 88-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Lot number: UNKNOWN) via an unspecified route of administration on 06Feb2021 (at the age of 88-years-old) as a single dose for COVID-19 immunization. Medical history included atrial flutter from an unspecified date and unspecified if ongoing. It was reported that the patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medications (within two weeks) included warfarin sodium (COUMADIN). It was reported that the patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccination. The patient experienced two complex seizures, serious for hospitalization, on 10Feb2021. The clinical course was reported as follows: "Two complex seizures confirmed by ED (emergency department) physician. No history of seizures. Negative CT head and labs. Unclear if seizure was related to COVID vaccine 5 days prior." It was reported that treatment was not received for the event. The clinical outcome of the event two complex seizures was recovered/resolved on an unspecified date. It was also reported that the patient had not tested positive for COVID-19 post vaccination.   No follow-up attempts are possible; information about lot number cannot be obtained.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of event Seizures cannot be excluded.  The case will be reassessed if additional information becomes available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus, Vaccination site pain
Clinical narrative: Severe Tinnitus; Slight soreness at injection site on 06Feb2021; This is a spontaneous report from a contactable consumer, the patient.  A 50-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9261), via an unspecified route of administration in the left arm on 06Feb2021 at 13:45 (at the age of 50-years-old) as a single dose for COVID-19 immunization.   Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19.  Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN), and simvastatin (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates and unknown if ongoing.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took oxycodone hydrochloride/paracetamol (PERCOCET) on unknown dates for an unknown indication and experienced drug allergy.  The patient experienced slight soreness at injection site on 06Feb2021 and severe tinnitus on 08Feb2021 at 05:00; both reported as serious for disability.  The tinnitus was further described as intermittent and constant buzzing and vibrations in right ear only. No other issues or symptoms. The patient did not receive any treatment for the events. The clinical outcomes of the tinnitus and slight soreness at injection site were not recovered.
Sex: F
Vaccine: COVID19
Symptoms: Platelet count, Thrombocytopenia
Clinical narrative: thrombocytopenia; This is a spontaneous report from a non-contactable consumer (the patient daughter).  A non-pregnant elderly female patient received  BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration, on an unspecified date as a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. It was unknown if the patient diagnosed with COVID-19.  It is unknown whether the patient received any other vaccines within four weeks prior to the vaccination.  On an unspecified date the patient experienced thrombocytopenia. The patient had lab tests and procedures performed which included platelet count: thrombocytopenia on an unknown date. It was unknown if treatment was received for the event.  The clinical outcome of thrombocytopenia was not recovered. If was unknown if since the vaccination, the patient had been tested for COVID-19.  Information on the lot number has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cerebrovascular accident
Clinical narrative: stroke; This is a spontaneous report from a contactable consumer, the patient. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE solution for injection, Lot unknown, first dose) intramuscular on 01Feb2021 (at an unknown age) at single dose for COVID-19 vaccination. Medical history and concomitant medications were not reported. On 05Feb2021, four days after vaccination, the patient had a stroke. The outcome of the event stroke was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cerebrovascular accident, Injection site pain, Lymphadenopathy
Clinical narrative: stroke; This is a spontaneous report from a contactable consumer, the patient. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE solution for injection, Lot unknown, first dose) intramuscular on 01Feb2021 (at an unknown age) at single dose for COVID-19 vaccination. Medical history and concomitant medications were not reported. On 05Feb2021, four days after vaccination, the patient had a stroke. The outcome of the event stroke was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Facial paralysis, SARS-CoV-2 test
Clinical narrative: Bell's Palsy - L facial droop; This is a spontaneous report from a contactable physician.  A 76-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EK4176), intramuscularly on 22Jan2021 at 08:00 am on the left arm at single dose for COVID-19 immunization. Medical history included type 2 diabetes mellitus (DM 2), hypertension (HTN), hypersensitivity lung disease (HLD), and hepatitis C (Hep C) s/p treatment, all from an unknown date. Patient had no known allergies. Concomitant medication included acetylsalicylic acid (ASA), gabapentin, lisinopril, and an unspecified statin from unknown dates and indication. No other vaccines were received in four weeks. On 27Jan2021, it was reported that the patent experienced Bell's palsy - L facial droop which resulted in emergency room visit and required treatment of "Pred". The patient had no COVID prior to vaccination and was tested post vaccination on 27Jan2021 via nasal swab which had a negative result. The patient received the vaccine in a hospital. The outcome of the event was reported as recovering.; Sender's Comments: A possible contribution role of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) to the onset of event Bell's palsy cannot be excluded, due to temporal relationship.  The case will be reassessed should additional information become available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pain, Pain in extremity
Clinical narrative: Since my vaccination I have been having pain in my left leg muscles.  The pain is worse if I bend my leg very much.  It has been over two weeks since the vaccination and the pain is not getting better.  I contacted my doctor and he suggested that I report the incident.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus
Clinical narrative: itching and aching in muscle of left arm followed by redness spreading towards elbow
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site induration, Injection site pruritus, Injection site rash, Injection site swelling
Clinical narrative: On February 14, I had used the handlebar rotation exercise of a stationery bike for 5 minutes.  The next day I noticed a large swelling about the size of half a pear on the muscle where my Moderna injection was done.  It was as hard as a nut, red, and warm and itchy with a red rash around it.  I saw an urgent care medical person and was told it was probably a reaction to the exercise and that sometimes that happens after an injection.  I was told to use cold compresses, hydrocortison cream, and rest it.  I did this, for 5 days, but  though the swelling subsided, the rash continued to move around and down my arm.  I went back to urgent care on February 19 and was told that it looked better.  I was offered prednazone for it, but declined since I was still on Budesonide .  I was told it would probably clear up over the weekend.  On February 22  it hadn't cleared up so I saw  a PC.  She  noted the rash  had spread, but swelling had gone down.  She checked my lymph node under my left arm and noticed it was swollen.  She said it was most likely due to a mild infection in the arm where I had  received the vaccination.  She  prescribed  a Zpack and after 2 days, all symptoms were gone and I felt so much better.  This event happened 10 days after my vaccination.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site warmth, Lymphadenopathy, Rash, Rash erythematous
Clinical narrative: On February 14, I had used the handlebar rotation exercise of a stationery bike for 5 minutes.  The next day I noticed a large swelling about the size of half a pear on the muscle where my Moderna injection was done.  It was as hard as a nut, red, and warm and itchy with a red rash around it.  I saw an urgent care medical person and was told it was probably a reaction to the exercise and that sometimes that happens after an injection.  I was told to use cold compresses, hydrocortison cream, and rest it.  I did this, for 5 days, but  though the swelling subsided, the rash continued to move around and down my arm.  I went back to urgent care on February 19 and was told that it looked better.  I was offered prednazone for it, but declined since I was still on Budesonide .  I was told it would probably clear up over the weekend.  On February 22  it hadn't cleared up so I saw  a PC.  She  noted the rash  had spread, but swelling had gone down.  She checked my lymph node under my left arm and noticed it was swollen.  She said it was most likely due to a mild infection in the arm where I had  received the vaccination.  She  prescribed  a Zpack and after 2 days, all symptoms were gone and I felt so much better.  This event happened 10 days after my vaccination.
Age: 97.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Resident expired on 2-25-21
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Glossitis, Pharyngeal swelling
Clinical narrative: Throat swelling and tongue felt raw was given Benedryl (2) by Dr. in attendance and observed for around 45 minutes. Later that evening (about 4 hours later) heart had a series of strong, short, contractions. Continued for the next few day but less each day.  Followed up with cardiologist and was in regular rhythm but show him my left arm where I had a red circle (3 inches or so)  around injection site. Referred to PCP and they suggested no 2nd vaccination. If deemed in need of another Covid vaccination allergist should be consulted first.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Flushing, Paraesthesia oral, Rash
Clinical narrative: Cos tongue tingling and possible rash. was taken to ED by  RRT. She stated having flushing neck and cheeks, elevated blood pressure 138/115 to 140/73
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: patient received vaccination on 2/17, noticed redness and swelling on 2/25.  it is painful
Age: 72.0
Sex: U
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: Difficulty breathing, possible anxiety per patient, evaluated by EMS-cleared
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Fatigue, Nausea, Vomiting
Clinical narrative: extreme chills, fatigue, nausea, vomiting, diarrhea.  chills started morning of the day following vaccination.  Hours later extreme fatigue followed by nausea, vomiting and diarrhea. Today, 48 hours later feeling much better with slight nausea which appears to be better.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ischaemic stroke
Clinical narrative: Acute ischemic stroke
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cerebrovascular accident
Clinical narrative: Acute ischemic stroke
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: The patient received the Pfizer vaccine for the second dose instead of the Moderna vaccine.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Metabolic function test, Pain, Rash
Clinical narrative: 2 days after vaccine started with rash, body aches, joint pain. Treated but continues
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anti-cyclic citrullinated peptide antibody negative, Antinuclear antibody negative, Arthralgia, Arthritis reactive, Blood chloride normal
Clinical narrative: 2 days after vaccine started with rash, body aches, joint pain. Treated but continues
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood creatine phosphokinase normal, Blood creatinine normal, Blood glucose normal, Blood potassium normal, Blood sodium decreased
Clinical narrative: 2 days after vaccine started with rash, body aches, joint pain. Treated but continues
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: C-reactive protein normal, Carbon dioxide normal, Fatigue, Feeling hot, Haematocrit normal
Clinical narrative: 2 days after vaccine started with rash, body aches, joint pain. Treated but continues
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Haemoglobin normal, Headache, Interleukin level, Joint swelling, Muscle spasms
Clinical narrative: 2 days after vaccine started with rash, body aches, joint pain. Treated but continues
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Myalgia, Peripheral swelling, Pruritus, Rash, Rash pruritic
Clinical narrative: 2 days after vaccine started with rash, body aches, joint pain. Treated but continues
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Red blood cell sedimentation rate normal, Rheumatoid factor increased, Thyroxine free normal, Urticaria
Clinical narrative: 2 days after vaccine started with rash, body aches, joint pain. Treated but continues
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Fatigue, Headache, Lymphadenopathy, Malaise
Clinical narrative: 2 days after vaccine started with rash, body aches, joint pain. Treated but continues
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Myalgia, Rash, Vaccination site pain
Clinical narrative: 2 days after vaccine started with rash, body aches, joint pain. Treated but continues
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Swollen tongue, Tachycardia
Clinical narrative: The patient received his first dose of the Moderna vaccine. He reports that approximately 2 hours after the injection he began to have right sided tongue swelling. He was assessed in the ED. He had no facial swelling but there was right sided tongue swelling present. Oral airway was patent. Tachycardia was present (HR 116) and BP 197/96. He was given Benadryl, Solu-Medrol, and IV fluids. He was later considered stable and was dicharged 3 hours later.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Swollen tongue
Clinical narrative: The patient received his first dose of the Moderna vaccine. He reports that approximately 2 hours after the injection he began to have right sided tongue swelling. He was assessed in the ED. He had no facial swelling but there was right sided tongue swelling present. Oral airway was patent. Tachycardia was present (HR 116) and BP 197/96. He was given Benadryl, Solu-Medrol, and IV fluids. He was later considered stable and was dicharged 3 hours later.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Death
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure decreased, Chills, Diarrhoea, Electrocardiogram normal, Laboratory test normal
Clinical narrative: vomit, diarrhea, chills, lost consciousness, BP drop. Paramedics brought to ER. Given fluids, EKG,  and lab tests to make sure it wasn't heart related. Tests came back normal.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Loss of consciousness, Troponin normal, Vomiting
Clinical narrative: vomit, diarrhea, chills, lost consciousness, BP drop. Paramedics brought to ER. Given fluids, EKG,  and lab tests to make sure it wasn't heart related. Tests came back normal.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster, Rash
Clinical narrative: Shingles,prescribed: Valacyclovir, rash along radial nerve
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Dry mouth, Palpitations, Rash
Clinical narrative: 36 hours later, (approximately), I woke up with a rash. Under the both arms it looked like a sunburn. Across the chest an sides, it was spotty. The right side had more rash than the right, and both sides wrapped around to the back, about 2 inches, on both sides. Less going down the rest of the torso. Took Benadryl, 2-25 mg, 4 hours apart, for a total of 100 mg. 1:00PM, Feb. 26, rash faded significantly.  Also had a dry mouth and a bit of a racing heart, right after being given the vaccination & again when the rashes appeared. However, this could have been anxiety. Both times it went away after walking & deep breathing. Lasted for about 15 minutes each time.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Flushing, Immediate post-injection reaction, Panic reaction, Paraesthesia
Clinical narrative: Very hot, flushed immediately after injection. She felt panicky, lips, fingers/feet were tingling.  She cooled down and was back to normal within 20 minutes of vaccination. No other events reported thereafter.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia oral
Clinical narrative: Very hot, flushed immediately after injection. She felt panicky, lips, fingers/feet were tingling.  She cooled down and was back to normal within 20 minutes of vaccination. No other events reported thereafter.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Blood pressure increased, Dizziness
Clinical narrative: Patient was observed post Covid-19 immunization for 30 minutes based on pre-vaccination screening and reported to RN that she was feeling lightheaded and dizzy after about 20 minutes of observation. States she is feeling slightly anxious. BP 160/96 pulse 108 sat 98%. Patient is not reporting any other symptoms.  Patient reports a History of HTN and anxiety States she does not normally feel lightheaded/dizzy. States this BP is elevated for her. Patient given water and crackers, with slight relief of dizziness. EMS called and at pt side for evaluation. At 1212p, Bp 173/91, hr 94, sat 97% given cracker and water, which patient stated made her feel slightly better. EMS evaluating patient Emotional support provided. At 1220, BP 182/98, pulse down to 85, with sats at 95%. Patient feeling better. EMS transported patient to a quite space and continued to monitor. Patient speaking with husband as well. At 1242, EMS released stating patient feeling better and BP down to 160/90. Patient encouraged to discuss with PCP events.  She was provided with Vaccine Information Sheet and instruction to access the V-Safe system. Patient was observed post Covid-19 immunization for 30 minutes based on pre-vaccination screening and reported to RN that she was feeling lightheaded and dizzy after about 20 minutes of observation. States she is feeling slightly anxious. BP 160/96 pulse 108 sat 98%. Patient is not reporting any other symptoms.  Patient reports a History of HTN and anxiety States she does not normally feel lightheaded/dizzy. States this BP is elevated for her. Patient given water and crackers, with slight relief of dizziness. EMS called and at pt side for evaluation. At 1212p, Bp 173/91, hr 94, sat 97% given cracker and water, which patient stated made her feel slightly better. EMS evaluating patient Emotional support provided. At 1220, BP 182/98, pulse down to 85, with sats at 95%. Patient feeling better. EMS transported patient to a quite space and continued to monitor. Patient speaking with husband as well. At 1242, EMS released stating patient feeling better and BP down to 160/90. Patient encouraged to discuss with PCP events.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Product preparation error
Clinical narrative: undiluted 0.3ml vial was given to patient, the patient did not have any adverse affects reported
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site induration, Injection site swelling, Pruritus, Skin warm
Clinical narrative: One week after receiving the vaccine the location of the injection swelled up and became hard, hot and itchy covering the whole biceps area.  It is warm, sore but does not have any rash or any outward sign of skin rashes.  I took some Benadryl and I am watching the area for additional reactions
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria, Vaccine positive rechallenge
Clinical narrative: Body-wide urticaria.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Dermatitis acneiform, Rash, Throat irritation
Clinical narrative: Patient experienced razor-burn like rash all over her body, except the face. She has been drinking lots of water to help with the symptoms but no help. Patient also experiencing burning sensation in throat area. She called her doctor to get medication to help treat symptoms and tried Prednisone 10mg three times per day for 5 days, but is still experiencing adverse effect.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, Injection site pain, Malaise, Nausea, Neck pain
Clinical narrative: Developed 101.1 fever starting 12 hours after injection. Went from 99.9 at first onset. Next day grew to 101.1 degrees. Finally fever broke in early morning hours after 1-1/2 days of feeling ill. Stayed hydrated with 7-up and water every hour or so, no food. Slight bit of nausea. Normal temperature is 97.6. Some aches in neck area, slight hurt at injection site.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Developed 101.1 fever starting 12 hours after injection. Went from 99.9 at first onset. Next day grew to 101.1 degrees. Finally fever broke in early morning hours after 1-1/2 days of feeling ill. Stayed hydrated with 7-up and water every hour or so, no food. Slight bit of nausea. Normal temperature is 97.6. Some aches in neck area, slight hurt at injection site.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Haemoptysis
Clinical narrative: 3 days after vaccine started coughing up blood clots. Started off as a couple small clots then within a half hour later I coughed up the size of a quarter Went to ER and then was admitted.; This is a spontaneous report from a contactable consumer (patient). A 69-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EL9269), intramuscular at the right arm on 05Feb2021 13:30 at single dose for COVID-19 immunization. The patient's medical history included rheumatoid arthritis (RA), transient ischaemic attack (TIA), atrial fibrillation (AFib), thyroid nodules, and back surgery. The patient's concomitant medications included methotrexate, atorvastatin, rivaroxaban (XARELTO), ergocalciferol (VIT D), and zinc. The patient was not pregnant at the time of vaccination. The patient previously took sulfur and acetylsalicylic acid;oxycodone hydrochloride (PERCODAN). The patient previously received the first dose of BNT162B2 (lot number: EL8982) on 15Jan2021, 01:30 PM at left arm for COVID-19 immunization. On 08Feb2021 23:45, 3 days after vaccine started, patient experienced coughing up blood clots. It started off as a couple small clots then within a half hour later, she coughed up the size of a quarter. She went to the emergency room (ER) and then was admitted for 3 days. The patient underwent lab tests and procedures which included nasal swab: negative on 09Feb2021. The patient had Cat Scans and broncoscopy as treatment for the event. Facility were the most recent COVID-19 vaccine was administered was reported as other. The outcome of the event was recovered on Feb2021.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test normal, Computerised tomogram normal, Epistaxis, Haemoptysis, Thrombosis
Clinical narrative: 3 days after vaccine started coughing up blood clots. Started off as a couple small clots then within a half hour later I coughed up the size of a quarter Went to ER and then was admitted.; This is a spontaneous report from a contactable consumer (patient). A 69-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EL9269), intramuscular at the right arm on 05Feb2021 13:30 at single dose for COVID-19 immunization. The patient's medical history included rheumatoid arthritis (RA), transient ischaemic attack (TIA), atrial fibrillation (AFib), thyroid nodules, and back surgery. The patient's concomitant medications included methotrexate, atorvastatin, rivaroxaban (XARELTO), ergocalciferol (VIT D), and zinc. The patient was not pregnant at the time of vaccination. The patient previously took sulfur and acetylsalicylic acid;oxycodone hydrochloride (PERCODAN). The patient previously received the first dose of BNT162B2 (lot number: EL8982) on 15Jan2021, 01:30 PM at left arm for COVID-19 immunization. On 08Feb2021 23:45, 3 days after vaccine started, patient experienced coughing up blood clots. It started off as a couple small clots then within a half hour later, she coughed up the size of a quarter. She went to the emergency room (ER) and then was admitted for 3 days. The patient underwent lab tests and procedures which included nasal swab: negative on 09Feb2021. The patient had Cat Scans and broncoscopy as treatment for the event. Facility were the most recent COVID-19 vaccine was administered was reported as other. The outcome of the event was recovered on Feb2021.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vascular cauterisation
Clinical narrative: 3 days after vaccine started coughing up blood clots. Started off as a couple small clots then within a half hour later I coughed up the size of a quarter Went to ER and then was admitted.; This is a spontaneous report from a contactable consumer (patient). A 69-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EL9269), intramuscular at the right arm on 05Feb2021 13:30 at single dose for COVID-19 immunization. The patient's medical history included rheumatoid arthritis (RA), transient ischaemic attack (TIA), atrial fibrillation (AFib), thyroid nodules, and back surgery. The patient's concomitant medications included methotrexate, atorvastatin, rivaroxaban (XARELTO), ergocalciferol (VIT D), and zinc. The patient was not pregnant at the time of vaccination. The patient previously took sulfur and acetylsalicylic acid;oxycodone hydrochloride (PERCODAN). The patient previously received the first dose of BNT162B2 (lot number: EL8982) on 15Jan2021, 01:30 PM at left arm for COVID-19 immunization. On 08Feb2021 23:45, 3 days after vaccine started, patient experienced coughing up blood clots. It started off as a couple small clots then within a half hour later, she coughed up the size of a quarter. She went to the emergency room (ER) and then was admitted for 3 days. The patient underwent lab tests and procedures which included nasal swab: negative on 09Feb2021. The patient had Cat Scans and broncoscopy as treatment for the event. Facility were the most recent COVID-19 vaccine was administered was reported as other. The outcome of the event was recovered on Feb2021.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Induration, Pain, Pruritus, Tenderness
Clinical narrative: Soreness, tenderness, redness, hardness Very itchy  Notes:  Having trouble with the form and cannot enter this info anywhere else other than here Item #06: Age = 68 and 0 months Item #22: Date Given for Dose #1 = 01/27/2021
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Lethargy, Lymphadenopathy, Nodule
Clinical narrative: After vaccine I had a headache and was lethargic and took Tylenol, next day I took Tylenol and Movic and started feeling better but yesterday I got this nodule on my neck that I can move around. My lymph node is enlarged
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Malaise, Pain, Pyrexia
Clinical narrative: Body aches, chills, fever, unwell
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Adverse drug reaction, Erythema, Pruritus, Pustule
Clinical narrative: Unexplained itching around the neck, redness from scratching overnight. Pustules noticed last night (2/25/2021). Adverse reaction did occur from February 23rd through 26.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pyrexia, SARS-CoV-2 antibody test negative, SARS-CoV-2 test negative
Clinical narrative: Woke up with a low fever, muscle aches and chills
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Deafness
Clinical narrative: Lost hearing in my right ear; This is a spontaneous report from a contactable consumer, the patient.  A 77-years-old non-pregnant female patient  received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: Unknown), via an unspecified route of administration from  in the left arm on 23Jan2021 at 15:00 (at the age of 77-years-old) as a single dose, for COVID-19 vaccination The patient medical history and concomitant medications were not reported. The patient had no known  allergies.  On 12Feb2021 at 18:00, The patient experienced lost hearing in my right ear (medically significant).  No treatment was given for the event. The clinical outcome of the event lost hearing in right ear was not recovered.  Information on Lot number was requested.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Dental discomfort, Dysgeusia, Gingival swelling, Limb discomfort, Lip swelling
Clinical narrative: pt stated after she received the vax she got a strange taste in her mouth.  At 1 AM pt woke up with a heavy feeling in her left arm.  Her left arm, hand and fingers started to swell.  At 3 AM her head felt warm and the entire left side of her face was swollen, including lips, gums, nose and eyelids.  Her teeth felt strange.  At 5AM she could feel a sensation going down the left inside of her body moving from her neck to her toe.  Then the right side of her face started to swell from the neck to the top of her head.  Pt woke up at 7 AM next day and the swelling was starting to go down on the right side.  On 2/26/2021 she is noticing the swelling is going down out of her left side.  She never really had any pain or discomfort just swelling.  Pt. has not contacted her PCP at this time.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Sensory disturbance, Skin warm, Swelling, Swelling face
Clinical narrative: pt stated after she received the vax she got a strange taste in her mouth.  At 1 AM pt woke up with a heavy feeling in her left arm.  Her left arm, hand and fingers started to swell.  At 3 AM her head felt warm and the entire left side of her face was swollen, including lips, gums, nose and eyelids.  Her teeth felt strange.  At 5AM she could feel a sensation going down the left inside of her body moving from her neck to her toe.  Then the right side of her face started to swell from the neck to the top of her head.  Pt woke up at 7 AM next day and the swelling was starting to go down on the right side.  On 2/26/2021 she is noticing the swelling is going down out of her left side.  She never really had any pain or discomfort just swelling.  Pt. has not contacted her PCP at this time.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling of eyelid
Clinical narrative: pt stated after she received the vax she got a strange taste in her mouth.  At 1 AM pt woke up with a heavy feeling in her left arm.  Her left arm, hand and fingers started to swell.  At 3 AM her head felt warm and the entire left side of her face was swollen, including lips, gums, nose and eyelids.  Her teeth felt strange.  At 5AM she could feel a sensation going down the left inside of her body moving from her neck to her toe.  Then the right side of her face started to swell from the neck to the top of her head.  Pt woke up at 7 AM next day and the swelling was starting to go down on the right side.  On 2/26/2021 she is noticing the swelling is going down out of her left side.  She never really had any pain or discomfort just swelling.  Pt. has not contacted her PCP at this time.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature decreased, Death, Dyspnoea, Peripheral coldness, Pulse abnormal
Clinical narrative: On the evening of 2/23/221 at 9:00 pm, resident reported feeling SOB, BP 80/44, Pulse 53, O2Sat 95% on 3L oxygen, hands cold, pulse weak. Temp 92.5F MD notified. EMS activated. EMS arrival and HR 20. Family refused transport to ER. Resident expired at 2:40 am on 2/24/21 Meds continued: duloextine, VITd2,hydralazine, synthroid, lisinopril, mag ox, folplex, pantoprazole, potassium chloride, ellipta, ensure, hydrocortisone cream, boost, deprox, xanax, morphine, lorazepam, tylenol, albuterol inhlation, ventolin inh.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Chest discomfort, Dizziness, Dyspnoea, Erythema
Clinical narrative: (2/25/2021) PATIENT REPORTS TO OFF-SITE COVID-19 VACCINE CLINIC. PATIENT FILLS OUT VACCINE CHECKLIST AND IT IS NOTED THAT PATIENT HAS PREVIOUS ISSUES WITH FLU SHOT WITH A HISTORY OF TORUBLE BREATHING. TEACHING IS PROVIDED WITH PATIENT REGARDING POSSIBLE SIMILAR REACTIONS WITH COVID-19 VACCINE AND THAT SHE SHOULD STAY AT LEAST 30 MINUTES AFTER VACCINATION IF SHE WISHES TO PROCEED. PATIENT CONSENT TO PROCEED WITH COVID-19 VACCINATION. VACCINE IS GIVEN AT 1000 INTO RIGHT ARM AND PATIENT IS ASKED TO STAY FOR OBSERVATION. AT 1030 PATIENT REPORTS TO THIS NURSE ITCHING AND HIVES.  PATIENT IS OBSERVED TO HAVE HIVES COVERING BILATERAL ARMS AND CHEST.  PATIENT DENIES BREATHING TROUBLE AT THIS TIME.  EMERGENCY REACTION KIT IS BROUGHT TO PATIENT?S TABLE. AT 1032 ON CALL PROVIDER IS NOTIFIED OF REACTION AND ORDERS ARE GIVEN FOR BENADRYL 50MG IM.  THIS IS GIVEN AT 1034  RN INTO GUTEAL AND PATIENT IS OBSERVED AND VS OBTAINED.  AT 1040 PATIENT STATES HER THROAT FEELS ?SCRATCHY? AND ?TIGHT.? IT IS RECOMMENDED TO PATIENT SHE SHOULD BE SEEN IN THE EMERGENCY ROOM.  PATIENT AGREES TO THIS IF SHE IS ABLE TO DRIVE HERSELF.  PATIENT IS FOLLOWED IN HER VEHICLE TO EMERGENCY ROOM FROM OFF-SITE CLINIC (APPROX. 8 BLOCKS).  ON CALL PROVIDER IS NOTIFIED AND HOSPITAL EMERGENCY ROOM IS GIVEN REPORT FROM THIS NURSE. UPON ARRIVAL TO ER PATIENT IS SEEN PER MD.  PATIENT REPORTS SYMPTOMS OF CHEST PRESSURE, DYSPNEA, LIGHT HEADEDNESS, ABDOMINAL PAIN, RASH, REDNESS, WARTHM AND ITCHING.  PATIENT IS GIVEN 0.4 MG SUBCU ADRENALINE AND 40 MG PREDNISONE ORALLY. PATIENT IS OBSERVED IN EMERGENCY ROOM x 1 HOUR.  PATIENT REPORTS SHE IS STARTING TO FEEL BETTER.  PATIENT IS DISCHARGED TO AT 1206 FROM EMERGENCY ROOM.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Skin warm, Throat irritation, Throat tightness
Clinical narrative: (2/25/2021) PATIENT REPORTS TO OFF-SITE COVID-19 VACCINE CLINIC. PATIENT FILLS OUT VACCINE CHECKLIST AND IT IS NOTED THAT PATIENT HAS PREVIOUS ISSUES WITH FLU SHOT WITH A HISTORY OF TORUBLE BREATHING. TEACHING IS PROVIDED WITH PATIENT REGARDING POSSIBLE SIMILAR REACTIONS WITH COVID-19 VACCINE AND THAT SHE SHOULD STAY AT LEAST 30 MINUTES AFTER VACCINATION IF SHE WISHES TO PROCEED. PATIENT CONSENT TO PROCEED WITH COVID-19 VACCINATION. VACCINE IS GIVEN AT 1000 INTO RIGHT ARM AND PATIENT IS ASKED TO STAY FOR OBSERVATION. AT 1030 PATIENT REPORTS TO THIS NURSE ITCHING AND HIVES.  PATIENT IS OBSERVED TO HAVE HIVES COVERING BILATERAL ARMS AND CHEST.  PATIENT DENIES BREATHING TROUBLE AT THIS TIME.  EMERGENCY REACTION KIT IS BROUGHT TO PATIENT?S TABLE. AT 1032 ON CALL PROVIDER IS NOTIFIED OF REACTION AND ORDERS ARE GIVEN FOR BENADRYL 50MG IM.  THIS IS GIVEN AT 1034  RN INTO GUTEAL AND PATIENT IS OBSERVED AND VS OBTAINED.  AT 1040 PATIENT STATES HER THROAT FEELS ?SCRATCHY? AND ?TIGHT.? IT IS RECOMMENDED TO PATIENT SHE SHOULD BE SEEN IN THE EMERGENCY ROOM.  PATIENT AGREES TO THIS IF SHE IS ABLE TO DRIVE HERSELF.  PATIENT IS FOLLOWED IN HER VEHICLE TO EMERGENCY ROOM FROM OFF-SITE CLINIC (APPROX. 8 BLOCKS).  ON CALL PROVIDER IS NOTIFIED AND HOSPITAL EMERGENCY ROOM IS GIVEN REPORT FROM THIS NURSE. UPON ARRIVAL TO ER PATIENT IS SEEN PER MD.  PATIENT REPORTS SYMPTOMS OF CHEST PRESSURE, DYSPNEA, LIGHT HEADEDNESS, ABDOMINAL PAIN, RASH, REDNESS, WARTHM AND ITCHING.  PATIENT IS GIVEN 0.4 MG SUBCU ADRENALINE AND 40 MG PREDNISONE ORALLY. PATIENT IS OBSERVED IN EMERGENCY ROOM x 1 HOUR.  PATIENT REPORTS SHE IS STARTING TO FEEL BETTER.  PATIENT IS DISCHARGED TO AT 1206 FROM EMERGENCY ROOM.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: (2/25/2021) PATIENT REPORTS TO OFF-SITE COVID-19 VACCINE CLINIC. PATIENT FILLS OUT VACCINE CHECKLIST AND IT IS NOTED THAT PATIENT HAS PREVIOUS ISSUES WITH FLU SHOT WITH A HISTORY OF TORUBLE BREATHING. TEACHING IS PROVIDED WITH PATIENT REGARDING POSSIBLE SIMILAR REACTIONS WITH COVID-19 VACCINE AND THAT SHE SHOULD STAY AT LEAST 30 MINUTES AFTER VACCINATION IF SHE WISHES TO PROCEED. PATIENT CONSENT TO PROCEED WITH COVID-19 VACCINATION. VACCINE IS GIVEN AT 1000 INTO RIGHT ARM AND PATIENT IS ASKED TO STAY FOR OBSERVATION. AT 1030 PATIENT REPORTS TO THIS NURSE ITCHING AND HIVES.  PATIENT IS OBSERVED TO HAVE HIVES COVERING BILATERAL ARMS AND CHEST.  PATIENT DENIES BREATHING TROUBLE AT THIS TIME.  EMERGENCY REACTION KIT IS BROUGHT TO PATIENT?S TABLE. AT 1032 ON CALL PROVIDER IS NOTIFIED OF REACTION AND ORDERS ARE GIVEN FOR BENADRYL 50MG IM.  THIS IS GIVEN AT 1034  RN INTO GUTEAL AND PATIENT IS OBSERVED AND VS OBTAINED.  AT 1040 PATIENT STATES HER THROAT FEELS ?SCRATCHY? AND ?TIGHT.? IT IS RECOMMENDED TO PATIENT SHE SHOULD BE SEEN IN THE EMERGENCY ROOM.  PATIENT AGREES TO THIS IF SHE IS ABLE TO DRIVE HERSELF.  PATIENT IS FOLLOWED IN HER VEHICLE TO EMERGENCY ROOM FROM OFF-SITE CLINIC (APPROX. 8 BLOCKS).  ON CALL PROVIDER IS NOTIFIED AND HOSPITAL EMERGENCY ROOM IS GIVEN REPORT FROM THIS NURSE. UPON ARRIVAL TO ER PATIENT IS SEEN PER MD.  PATIENT REPORTS SYMPTOMS OF CHEST PRESSURE, DYSPNEA, LIGHT HEADEDNESS, ABDOMINAL PAIN, RASH, REDNESS, WARTHM AND ITCHING.  PATIENT IS GIVEN 0.4 MG SUBCU ADRENALINE AND 40 MG PREDNISONE ORALLY. PATIENT IS OBSERVED IN EMERGENCY ROOM x 1 HOUR.  PATIENT REPORTS SHE IS STARTING TO FEEL BETTER.  PATIENT IS DISCHARGED TO AT 1206 FROM EMERGENCY ROOM.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Alanine aminotransferase increased, Aspartate aminotransferase increased, Asthenia, Blood creatinine increased
Clinical narrative: 2/24/21 Patient Died.  02/23/21. Patient came to ED for weakness/falls. Patient had fallen on 02/21 and 02/23. UA was done in LTC, and he was started on ciprofloxacin 02/22/21. Treatment was to put patient on comfort cares (morphine + lorazepam)